Digest Réseau Comment ça marche
Réseau
/
Sociétés
Te
Non vérifié

Teva Pharmaceutical Industries Ltd

Ce que nous écrivons

Annonces ÉconomiquesFinanceIndustrie pharmaceutiqueManagement/Organisation d'EntrepriseMédecine Santé Bien-être

91 communiqués de presse

Voir tous les communiqués de presse
19/03/2026
Industrie pharmaceutique
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1.00
0
19/03/2026
Industrie pharmaceutique
Finance
Teva Releases Q1 2026 Aide Memoire
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1.00
0
03/03/2026
Industrie pharmaceutique
Finance
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1.00
0
24/02/2026
Industrie pharmaceutique
Teva to Present at the Upcoming Investor Conferences in March
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1.00
0
20/02/2026
Industrie pharmaceutique
Annonces Économiques
U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1.00
0
17/02/2026
Industrie pharmaceutique
Teva and Sanofi’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1.00
0
28/01/2026
Industrie pharmaceutique
Management/Organisation d'Entreprise
Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecutive Year of Growth; Pipeline Positioned to Unlock Significant Value Potential
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1.00
0
27/01/2026
Industrie pharmaceutique
Médecine Santé Bien-être
Will Forte Teams Up with Teva to Get Real About Huntington’s Disease with ‘Honestly HD’
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1.00
0
14/01/2026
Industrie pharmaceutique
Médecine Santé Bien-être
Annonces Économiques
AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1.00
0
11/01/2026
Industrie pharmaceutique
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1.00
0

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0